A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

11 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

3 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

464 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.